Abstract 6622: Novel selective binders for gastrointestinal DCLK1 isoforms.

Abstract Doublecortin-like kinase 1 (DCLK1) is a microtubule-associated protein kinase that plays a critical role in the maintenance of gastrointestinal (GI) epithelial integrity and regeneration. Emerging evidence highlights the functional divergence of its isoforms—particularly the long and short forms—which are differentially expressed during homeostasis and disease. In healthy GI tissue, DCLK1-long primarily maintains stem cell quiescence and epithelial repair. Conversely, DCLK1-short is markedly elevated in several GI malignancies and is associated with oncogenic transformation, invasion, and poor prognosis. We are investigating compounds that modulate DCLK1 isoforms to mitigate irradiation-induced gastrointestinal acute radiation syndrome (GI-ARS). Our research demonstrates that 2-deoxyglucose (2DG) and its non-metabolizable analogue differentially regulate crypt and colonoid growth in ex vivo systems. Treatment with 2DG results in selective suppression of the DCLK1-short isoform while sparing or modestly enhancing the DCLK1-long variant, suggesting a potential therapeutic window for targeting tumor-specific isoform expression. To further identify molecular binders capable of modulating DCLK1 activity, we employed a structure-based virtual screening approach using a focused library of 100,000 small molecules. High-throughput in silico docking enabled the identification of several high-affinity lead compounds with potential isoform-selective binding. The strategy of small-molecule screening offers a promising approach for selective intervention in DCLK1-driven pathologies in GI tissue repair. Citation Format: Uzma Uzmi, Shahid Umar, Prashanthi Karyala, Rao VL Papineni. Novel selective binders for gastrointestinal DCLK1 isoforms [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6622.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-6622
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 6622: Novel selective binders for gastrointestinal DCLK1 isoforms.

Prashanthi Karyala, Rao VL Papineni, Uzma Uzmi, Shahid Umar
Cancer Research
Protein Degradation and Inhibitors
article

Abstract 6622: Novel selective binders for gastrointestinal DCLK1 isoforms.

Prashanthi Karyala, Rao VL Papineni, Uzma Uzmi, Shahid Umar
article en

Abstract

Abstract Doublecortin-like kinase 1 (DCLK1) is a microtubule-associated protein kinase that plays a critical role in the maintenance of gastrointestinal (GI) epithelial integrity and regeneration. Emerging evidence highlights the functional divergence of its isoforms—particularly the long and short forms—which are differentially expressed during homeostasis and disease. In healthy GI tissue, DCLK1-long primarily maintains stem cell quiescence and epithelial repair. Conversely, DCLK1-short is markedly elevated in several GI malignancies and is associated with oncogenic transformation, invasion, and poor prognosis. We are investigating compounds that modulate DCLK1 isoforms to mitigate irradiation-induced gastrointestinal acute radiation syndrome (GI-ARS). Our research demonstrates that 2-deoxyglucose (2DG) and its non-metabolizable analogue differentially regulate crypt and colonoid growth in ex vivo systems. Treatment with 2DG results in selective suppression of the DCLK1-short isoform while sparing or modestly enhancing the DCLK1-long variant, suggesting a potential therapeutic window for targeting tumor-specific isoform expression. To further identify molecular binders capable of modulating DCLK1 activity, we employed a structure-based virtual screening approach using a focused library of 100,000 small molecules. High-throughput in silico docking enabled the identification of several high-affinity lead compounds with potential isoform-selective binding. The strategy of small-molecule screening offers a promising approach for selective intervention in DCLK1-driven pathologies in GI tissue repair. Citation Format: Uzma Uzmi, Shahid Umar, Prashanthi Karyala, Rao VL Papineni. Novel selective binders for gastrointestinal DCLK1 isoforms [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6622.

Cancer ResearchVol. 86(7_Supplement)
M S Ramaiah University of Applied Sciences (IN), Brantford Energy (Canada) (CA), University of Kansas Medical Center (US), M.S. Ramaiah Medical College (IN)
No poverty
Openalex Percentile: Top 7%
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.